Guidelines for Intravenous Thrombolysis (Recombinant Tissue-type Plasminogen Activator), the Third Edition, March 2019: A Guideline from the Japan Stroke Society

Neurol Med Chir (Tokyo). 2019 Dec 15;59(12):449-491. doi: 10.2176/nmc.st.2019-0177. Epub 2019 Dec 5.
No abstract available

Keywords: Guideline; Japan; acute ischemic stroke; alteplase; thrombolysis.

Publication types

  • Practice Guideline

MeSH terms

  • Angiography
  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use
  • Aortic Dissection / complications
  • Aortic Dissection / diagnosis
  • Brain Ischemia / complications
  • Brain Ischemia / diagnostic imaging
  • Brain Ischemia / drug therapy*
  • Brain Ischemia / therapy
  • Cerebral Hemorrhage / etiology
  • Clinical Trials as Topic / statistics & numerical data
  • Combined Modality Therapy
  • Comorbidity
  • Contraindications, Drug
  • Contraindications, Procedure
  • Drug Administration Schedule
  • Drug Interactions
  • Emergency Medical Services
  • Evidence-Based Medicine
  • Fibrinolytic Agents / administration & dosage
  • Fibrinolytic Agents / adverse effects
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Hypoglycemia / blood
  • Hypoglycemia / complications
  • Informed Consent
  • Infusions, Intravenous
  • Japan
  • Mechanical Thrombolysis
  • Neuroimaging
  • Patient Selection
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / adverse effects
  • Recombinant Proteins / therapeutic use
  • Thrombolytic Therapy / methods
  • Thrombolytic Therapy / standards*
  • Time-to-Treatment
  • Tissue Plasminogen Activator / administration & dosage
  • Tissue Plasminogen Activator / adverse effects
  • Tissue Plasminogen Activator / therapeutic use*

Substances

  • Anticoagulants
  • Fibrinolytic Agents
  • Recombinant Proteins
  • Tissue Plasminogen Activator